- This event has passed.
What do you know about the legal cases fighting for the right to access therapeutic use of psilocybin?
June 19, 2024 @ 12:00 pm - 1:30 pm
$10
- Psychedelics and Attachment: Fundamentals, Implications, and New Frontiers - April 15, 2025
- Indigenous Reciprocity Initiative (IRI) Support Internship (OPEN) - April 10, 2025
- Development Outreach Internship (OPEN) - April 10, 2025
Join our discussion on the groundbreaking efforts to establish federal safe harbor for psilocybin-assisted therapy for individuals with life-threatening conditions. We’ll explore the current legal status of psilocybin as a Schedule I substance, the challenges this poses for access to therapy, and potential pathways for change, including the Right to Try Act and rescheduling efforts. We’ll also delve into the significant litigation, AIMS et al v. DEA, and its impact on inspiring federal bills like the Right to Try Clarification Act and the Breakthrough Therapies Act. This is a critical conversation about expanding treatment options and improving access to innovative therapies. This community forum will be led by Kathryn L. Tucker, a national leader in improving care for seriously ill patients, with advocacy roles at organizations like the National Psychedelics Association and Compassion & Choices. Britt Rollins, who is a co-founder of the National Psychedelics Association and a seasoned communications strategist in healthcare, will be the interviewer in this forum.
